Anti-Bovine CSN1S1/Bos d 8 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22213; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The Anti-Bovine CSN1S1/Bos d 8 Polyclonal Antibody is a highly specific and sensitive tool for detecting the presence of bovine CSN1S1 (Casein alpha S1) protein in various biological samples. This antibody is produced using state-of-the-art technology and has been extensively validated for use in a wide range of applications.
CSN1S1, also known as Bos d 8, is a major milk protein found in bovine milk. It plays a crucial role in the formation and stabilization of milk casein micelles, which are responsible for the white color and nutritional properties of milk. CSN1S1 is also known to have immunomodulatory properties and has been linked to allergic reactions in some individuals.
The Anti-Bovine CSN1S1/Bos d 8 Polyclonal Antibody is an essential tool for researchers studying milk proteins and their functions. It is particularly useful in the fields of dairy science, food allergy research, and immunology. This antibody can be used for various techniques, including Western blotting, ELISA, immunohistochemistry, and immunofluorescence.
– Detection of CSN1S1 in bovine milk samples: The Anti-Bovine CSN1S1/Bos d 8 Polyclonal Antibody has been extensively used to detect the presence of CSN1S1 protein in bovine milk samples. This is crucial for quality control and to ensure the purity of dairy products.
– Investigating the role of CSN1S1 in milk allergies: This antibody has been used in studies to understand the involvement of CSN1S1 in milk allergies. It can be used to quantify the levels of CSN1S1 in milk samples from individuals with different levels of milk allergy.
– Immunohistochemical staining of CSN1S1 in tissues: The Anti-Bovine CSN1S1/Bos d 8 Polyclonal Antibody has been successfully used for immunohistochemical staining of CSN1S1 in various tissues, including mammary gland tissue. This allows for the visualization and localization of CSN1S1 in tissues, aiding in the understanding of its function.
In conclusion, the Anti-Bovine CSN1S1/Bos d 8 Polyclonal Antibody is a highly reliable and specific tool for the detection and study of bovine CSN1S1 protein. Its versatility and sensitivity make it an indispensable tool for researchers in the field of dairy science, food allergy, and immunology. Order now and take the first step towards unlocking the secrets of milk proteins.
ProteoGenix catalogue number ARO-A22213. For research use only.
Target: Alpha-S1-casein, Bos d 8, Antioxidant peptide, CSN1S1; Clonality: Polyclonal Antibody; Reactivity: Bovine; Applications: IHC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Bovine |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
